Data Availability
Data availability statement not applicable to this paper.
References
Kovacs G, Robrecht S, Fink AM et al (2016) Minimal residual disease assessment improves prediction of outcome in patients with chronic lymphocytic Leukemia (CLL) who achieve partial response: comprehensive analysis of two phase III Studies of the German CLL Study Group. J Clin Oncol 34(31):3758–3765. https://doi.org/10.1200/JCO.2016.67.1305
Liu D, Chen Z, Wang T, Zhang B, Zhou H, Li Q (2017) Littoral-cell angioma of the spleen: a case report. Cancer Biol Med 14(2):194–195. https://doi.org/10.20892/j.issn.2095-3941.2016.0094
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
The study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Informed consent was obtained from the patient.
Consent for publication
The participant has consented to the submission of the case report to the journal.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Cellini, A., Scarmozzino, F., Friziero, A. et al. Persistent splenomegaly due to littoral cell angiomatosis in venetoclax-induced undetectable minimal residual disease of chronic lymphocytic leukemia. Ann Hematol 102, 681–682 (2023). https://doi.org/10.1007/s00277-022-05067-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-022-05067-4